TXO Energy Partners LP (TXO) is set to become the year's first listing from the energy sector, and the second US IPO to raise $100mm+. The US oil and gas producer is scheduled to trade on Friday. Led by experienced oilman Bob Simpson, TXO has...read more
There are currently no IPOs scheduled for the first week of January, though we could see some notable launches as we enter the new year. Several large issuers in the pipeline have kept their prospectuses fresh over the past year. Leading the lineup is...read more
One deal is expected to price in the week ahead. Although, it is not large enough to be included in our IPO stats. After delaying its public debut, BullFrog AI Holdings (BFAI), is scheduled to price in the coming week. It plans to raise...read more
It was the IPO market's slowest November in six years as just four deals raised a combined $166 million. The month's lineup was led by $50+ million IPOs, biotech Acrivon Therapeutics (ACRV) and Chinese hotel chain ...read more
TXO Energy Partners prepares the year's first energy IPO
TXO Energy Partners LP (TXO) is set to become the year's first listing from the energy sector, and the second US IPO to raise $100mm+. The US oil and gas producer is scheduled to trade on Friday. Led by experienced oilman Bob Simpson, TXO has...read more
US IPO Week Ahead: IPO market could ring in the new year with notable launches
There are currently no IPOs scheduled for the first week of January, though we could see some notable launches as we enter the new year. Several large issuers in the pipeline have kept their prospectuses fresh over the past year. Leading the lineup is...read more
US IPO Week Ahead: December IPO market off to slow start
One deal is expected to price in the week ahead. Although, it is not large enough to be included in our IPO stats. After delaying its public debut, BullFrog AI Holdings (BFAI), is scheduled to price in the coming week. It plans to raise...read more
Renaissance Capital's November IPO Market Update
It was the IPO market's slowest November in six years as just four deals raised a combined $166 million. The month's lineup was led by $50+ million IPOs, biotech Acrivon Therapeutics (ACRV) and Chinese hotel chain ...read more